Online citations, reference lists, and bibliographies.

Prognostic Value Of Metabolic Tumor Volume And Total Lesion Glycolysis In Head And Neck Cancer: A Systematic Review And Meta-Analysis

Kyoungjune Pak, Gi Jeong Cheon, Hyun-Yeol Nam, Seong-Jang Kim, Keon Wook Kang, June-Key Chung, E. Edmund Kim, Dong Soo Lee
Published 2014 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
We conducted a comprehensive systematic review of the literature on volumetric parameters and a meta-analysis of the prognostic value of metabolic tumor volume (MTV) and total lesion glycolysis (TLG) in patients with head and neck cancer (HNC). Methods: A systematic search of MEDLINE and EMBASE was performed using the key words PET, head and neck, and volume. Inclusion criteria were 18F-FDG PET used as an initial imaging tool; studies limited to HNC; patients who had not undergone surgery, chemotherapy, or radiotherapy before PET scans; and studies reporting survival data. Event-free survival and overall survival were considered markers of outcome. The impact of MTV or TLG on survival was measured by the effect size hazard ratio (HR). Data from each study were analyzed using Review Manager. Results: Thirteen studies comprising 1,180 patients were included in this study. The combined HR for adverse events was 3.06 (2.33–4.01, P < 0.00001) with MTV and 3.10 (2.27–4.24, P < 0.00001) with TLG, meaning that tumors with high volumetric parameters were associated with progression or recurrence. Regarding overall survival, the pooled HR was 3.51 (2.62–4.72, P < 0.00001) with MTV and 3.14 (2.24–4.40, P < 0.00001) with TLG. There was no evidence of significant statistical heterogeneity at an I2 of 0%. Conclusion: MTV and TLG are prognostic predictors of outcome in patients with HNC. Despite clinically heterogeneous HNC and the various methods adopted between studies, we can confirm that patients with a high MTV or TLG have a higher risk of adverse events or death.
This paper references
10.1007/s00432-010-0972-y
18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis
Peng Xie (2010)
10.1097/MEG.0b013e328323d6fa
Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis
Lingling Pan (2009)
10.1007/s13566-012-0065-4
Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma
Adam A. Garsa (2012)
10.1111/j.1749-4486.2008.01688.x
A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy.
M G Isles (2008)
10.1016/j.ijrobp.2010.11.050
Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
Kristin Higgins (2012)
FDGPET/CT imaging biomarkers in head and neck squamous cell carcinoma
V Paidpally (2012)
10.1007/s00432-009-0729-7
Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma
Peng Xie (2009)
10.1093/annonc/mds247
Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynx.
Gi Cheol Park (2013)
10.1097/IGC.0b013e31829ee012
Prognostic Value of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography or PET-Computed Tomography in Cervical Cancer: A Meta-Analysis
Qianying Zhao (2013)
10.2214/AJR.08.1160
CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma.
Pim A de Jong (2009)
10.2214/AJR.12.9138
PET-based primary tumor volumetric parameters and survival of patients with non-small cell lung carcinoma.
Jessica M. Davison (2013)
10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.
M K Parmar (1998)
Wanghan , Jingui L . 18 FDG - PET / CT for the detection of regional nodal metastasis in patients with primary head and neck cancer before treatment : a meta - analysis
L Yongkui (2013)
10.1016/j.suronc.2013.02.002
18FDG-PET/CT for the detection of regional nodal metastasis in patients with primary head and neck cancer before treatment: a meta-analysis.
Lu Yong-kui (2013)
10.1002/hed.21400
Accuracy of whole-body PET and PET-CT in initial M staging of head and neck cancer: a meta-analysis.
Guo-Zeng Xu (2011)
10.2217/IIM.12.60
FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma.
Vasavi Paidpally (2012)
10.1093/jnci/djn125
18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.
Panayiotis A. Kyzas (2008)
18FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer: a meta-analysis
GZ Xu (2011)
10.1007/s00259-011-1893-y
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
Tejpal Gupta (2011)
10.1007/s00259-012-2127-7
Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy
C. Z. Kao (2012)
10.2967/jnumed.111.101402
18F-FDG PET/CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma
Remy Lim (2012)
10.2967/jnumed.111.099531
18F-FDG Metabolic Tumor Volume and Total Glycolytic Activity of Oral Cavity and Oropharyngeal Squamous Cell Cancer: Adding Value to Clinical Staging
Elizabeth H Dibble (2012)
10.3857/roj.2011.29.4.243
FDG-PET/CT as prognostic factor and surveillance tool for postoperative radiation recurrence in locally advanced head and neck cancer
Giwon Kim (2011)
10.1007/s13139-013-0260-2
Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology
Muhammad Kashif Rahim (2014)
10.1002/lary.23409
Comparison of whole body positron emission tomography (PET)/PET-computed tomography and conventional anatomic imaging for detecting distant malignancies in patients with head and neck cancer: a meta-analysis.
Guo-Zeng Xu (2012)
10.3348/kjr.2012.13.6.752
Prognostic Value of Volume-Based 18F-Fluorodeoxyglucose PET/CT Parameters in Patients with Clinically Node-Negative Oral Tongue Squamous Cell Carcinoma
Su Jin Lee (2012)
10.2967/jnumed.112.116053
Prognostic Value of Preoperative Metabolic Tumor Volume and Total Lesion Glycolysis Measured by 18F-FDG PET/CT in Salivary Gland Carcinomas
In Sun Ryu (2013)
10.1016/j.oraloncology.2012.09.005
Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
Yasser G Abd El-Hafez (2013)
10.3109/00016480903402981
Standardized uptake value is of prognostic value for outcome in head and neck squamous cell carcinoma
B Zhang (2010)
10.1016/S1536-1632(02)00011-2
Evaluation of response to neoadjuvant therapy by quantitative 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography in patients with esophageal cancer.
Nuri Arslan (2002)
10.1136/bmj.315.7109.629
Bias in meta-analysis detected by a simple, graphical test
Matthias Egger (1997)
10.1136/bmj.327.7414.557
Measuring inconsistency in meta-analyses
Julian P. T. Higgins (2003)
10.1007/s00259-012-2280-z
Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours
Christophe van de Wiele (2012)
Prognostic significance of SUVon PET/CT in patients with esophageal cancer: a systematic review and meta-analysis
L Pan (2009)
10.3348/kjr.2013.14.1.1
Prognostic Significance of Volume-Based PET Parameters in Cancer Patients
Seung Hwan Moon (2013)
10.1097/MNM.0b013e3283495662
Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification
Sheng-Chieh Chan (2011)
10.1017/S0266462305050154
Meta-analysis when only the median survival times are known: a comparison with individual patient data results.
Stefan Michiels (2005)
10.2967/jnumed.111.090696
Prognostic Significance of 18F-FDG PET Parameters and Plasma Epstein-Barr Virus DNA Load in Patients with Nasopharyngeal Carcinoma
K P Chang (2012)
10.1093/jnci/86.11.829
Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.
Doug G. Altman (1994)
18FDG PET and PET-CT for the detection of bone metastases in patients with head and neck cancer: a meta-analysis
X Yi (2013)
10.1158/1078-0432.CCR-08-3290
Metabolic Tumor Volume of [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Short-Term Outcome to Radiotherapy With or Without Chemotherapy in Pharyngeal Cancer
Man Ki Chung (2009)



This paper is referenced by
10.20663/IWATESHIGAKUKAISHI.44.2_37
Comparison of 18F-choline and 18F-FDG accumulation in PET imaging of oral squamous cell carcinoma
Yasufumi Hara (2019)
10.1007/s00405-016-4346-1
Prognostic value of tumoral heterogeneity and volumetric parameters as measured by F18-FDG PET/CT in sinonasal cancer
Bum Soo Kim (2016)
10.1097/RLU.0000000000002291
Prognostic Value of Volumetric Parameters of Pretreatment 18F-FDG PET/CT in Esophageal Cancer: A Systematic Review and Meta-analysis
Sangwon Han (2018)
10.1007/978-981-15-3188-0
Diagnostic Imaging in Head and Neck Cancer
Hiroya Ojiri (2020)
10.1016/j.ctro.2018.09.002
Potentials and challenges of diffusion-weighted magnetic resonance imaging in radiotherapy
Sara Leibfarth (2018)
10.1007/978-981-15-3188-0_10
PET in the Diagnosis of Head and Neck Cancer
Tetsuro Sekine (2020)
10.3802/jgo.2016.27.e15
Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer
Hyun Hoon Chung (2016)
10.1097/MD.0000000000001142
Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma
Kim Francis Andersen (2015)
10.1007/s11604-015-0495-1
Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma
Kazuhiro Kitajima (2015)
10.1245/s10434-016-5541-4
18F-FDG PET/CT Volumetric Parameters are Associated with Tumor Grade and Metastasis in Pancreatic Neuroendocrine Tumors in von Hippel–Lindau Disease
Kei Satoh (2016)
10.1016/j.amjoto.2017.10.009
Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
Kyoungjune Pak (2018)
10.1016/J.EJRAD.2019.02.006
Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features.
Arman Rahmim (2019)
10.1002/hed.25337
Pretreatment metabolic tumor volume as a prognostic factor in HPV‐associated oropharyngeal cancer in the context of AJCC 8th edition staging
John M Floberg (2018)
10.1007/s13193-018-0840-9
Organ Preservation Protocols in T4 Laryngeal Cancer: a Review of the Literature
Narayana Subramaniam (2018)
10.1002/hed.25622
Metabolic tumor volume and total lesion glycolysis predict tumor progression and survival after salvage surgery for recurrent oral cavity squamous cell carcinoma.
Woo Ri Choi (2019)
10.18632/oncotarget.25453
Lymph node density in papillary thyroid carcinoma is a prognostic factor after adjusting for pathological stage
Hidenori Suzuki (2018)
10.1186/s40644-020-00322-1
Clinical and prognostic value of tumor volumetric parameters in melanoma patients undergoing 18F-FDG-PET/CT: a comparison with serologic markers of tumor burden and inflammation
Christian Philipp Reinert (2020)
10.1007/978-981-10-0126-0_16
Meta-Analysis of Prognostic Studies Evaluating Time-Dependent Diagnostic and Predictive Capacities of Biomarkers
Satoshi Hattori (2017)
10.2399/jmu.2018001008
Predictive and prognostic values of pretreatment functional imaging-based biomarkers in advanced-stage laryngeal cancer
Görkem Eskiizmir (2018)
Role of Pre -Treatment FDG PET Quantitative Parameters in Prognostication of Head and Neck Squamous Cell Carcinoma-A Review
Narayana Subramaniam (2017)
10.1016/j.lungcan.2016.07.025
Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor.
Seung Hwan Moon (2016)
10.1016/J.ORALONCOLOGY.2019.04.011
Metabolic tumor volume of metastatic lymph nodes and survival after total laryngectomy in laryngeal and hypopharyngeal cancer.
Takashi Fujii (2019)
10.1002/hed.25040
Prognostic value of tumor volume in patients with head and neck squamous cell carcinoma treated with primary surgery
Daniel Dejaco (2018)
10.1097/MNM.0000000000000627
Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer
Xuee Zhu (2017)
10.1007/s00259-014-2972-7
PET imaging biomarkers in head and neck cancer
Sarah Differding (2014)
10.1007/s00432-018-2760-z
Pre-treatment metabolic tumor volume predicts tumor metastasis and progression in high-grade salivary gland carcinoma
Turki M. Almuhaimid (2018)
10.1155/2019/4051206
18F-FDG-PET/CT Imaging in Advanced Glottic Cancer: A Tool for Clinical Decision in Comparison with Conventional Imaging
Gaetano Paone (2019)
10.1007/s00259-018-4065-5
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis
Pierluigi Bonomo (2018)
10.1002/hed.24605
Clinical impact of 18F‐FDG positron emission tomography/CT on adenoid cystic carcinoma of the head and neck
Ji-Hoon Jung (2017)
10.1007/s12149-016-1131-6
Influence of volumetric 4′-[methyl-11C]-thiothymidine PET/CT parameters for prediction of the clinical outcome of head and neck cancer patients
Hiroshi Hoshikawa (2016)
10.21037/tro.2018.01.08
Prognostic effects of the metabolic tumor volume and total lesion glycolysis in patients with advanced squamous cell carcinoma of head and neck
He-Yuan Hsieh (2018)
10.1177/0300891619868012
Assessment of biological parameters in head and neck cancer based on in vivo distribution of 18F-FDG-FLT-FMISO-PET/CT images
Paulina Cegła (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar